Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,003 | 448 | 48.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,425 | 6 | 44.6% |
| Travel and Lodging | $1,103 | 5 | 6.6% |
| Education | $100.05 | 2 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $9,523 | 66 | $0 (2024) |
| Novo Nordisk Inc | $1,458 | 83 | $0 (2024) |
| PFIZER INC. | $1,071 | 53 | $0 (2024) |
| Lilly USA, LLC | $734.10 | 54 | $0 (2024) |
| GlaxoSmithKline, LLC. | $550.02 | 33 | $0 (2024) |
| Astellas Pharma US Inc | $528.78 | 18 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $401.70 | 24 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $279.53 | 17 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $220.84 | 11 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $194.93 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,702 | 150 | Novo Nordisk Inc ($518.01) |
| 2023 | $5,851 | 132 | ABBVIE INC. ($3,735) |
| 2022 | $1,330 | 83 | Novo Nordisk Inc ($276.34) |
| 2021 | $6,749 | 96 | AbbVie Inc. ($5,495) |
All Payment Transactions
461 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Gastroenterology | ||||||
| 12/19/2024 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: VACCINES | ||||||
| 12/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Oncology | ||||||
| 12/13/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: Endocrinology | ||||||
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Obesity | ||||||
| 12/04/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/04/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Neuroscience | ||||||
| 12/03/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $9.57 | General |
| 12/02/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: Diabetes | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Gastroenterology | ||||||
| 11/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.61 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: DIABETES | ||||||
| 11/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Obesity | ||||||
| 11/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Oncology | ||||||
| 10/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Biological | ||||||
| 10/17/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $28.50 | General |
| Category: RESPIRATORY | ||||||
| 10/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 146 | 220 | $39,136 | $13,415 |
| 2022 | 3 | 133 | 210 | $40,800 | $14,302 |
| 2021 | 6 | 193 | 277 | $51,932 | $17,521 |
| 2020 | 6 | 156 | 217 | $37,478 | $10,973 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 95 | $18,715 | $6,329 | 33.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 53 | 86 | $11,438 | $4,352 | 38.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 26 | 26 | $8,112 | $2,638 | 32.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 13 | $871.00 | $96.91 | 11.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 55 | 106 | $20,882 | $7,518 | 36.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 34 | 34 | $10,608 | $3,549 | 33.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 70 | $9,310 | $3,234 | 34.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 62 | 122 | $24,034 | $8,415 | 35.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 47 | 47 | $14,664 | $5,018 | 34.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 46 | 70 | $9,310 | $2,933 | 31.5% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 13 | 13 | $2,379 | $863.59 | 36.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 12 | 12 | $804.00 | $189.00 | 23.5% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 13 | 13 | $741.00 | $103.62 | 14.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 57 | 98 | $19,306 | $5,279 | 27.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 25 | 25 | $7,800 | $2,358 | 30.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 39 | 57 | $7,581 | $2,324 | 30.7% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 11 | 12 | $1,116 | $725.67 | 65.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 12 | 13 | $871.00 | $204.18 | 23.4% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 12 | 12 | $804.00 | $82.57 | 10.3% |
About Judith Caldwell, NP
Judith Caldwell, NP is a Nurse Practitioner healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1013992106.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Judith Caldwell, NP has received a total of $16,631 in payments from pharmaceutical and medical device companies, with $2,702 received in 2024. These payments were reported across 461 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($8,003).
As a Medicare-enrolled provider, Caldwell has provided services to 628 Medicare beneficiaries, totaling 924 services with total Medicare billing of $56,211. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Primary Care
- Location Nashville, TN
- Active Since 12/12/2005
- Last Updated 12/07/2017
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1013992106
Products in Payments
- VRAYLAR (Drug) $8,972
- ELIQUIS (Drug) $582.71
- Ozempic (Drug) $490.43
- TRELEGY ELLIPTA (Drug) $435.77
- Veozah (Drug) $428.79
- XIFAXAN (Drug) $401.70
- UBRELVY (Drug) $370.76
- MOUNJARO (Drug) $301.38
- Wegovy (Drug) $289.18
- PREVNAR 20 (Biological) $285.48
- Rybelsus (Drug) $248.62
- JARDIANCE (Drug) $215.06
- TRULICITY (Drug) $202.48
- NURTEC ODT (Drug) $194.30
- Cologuard Collection Kit (Device) $177.49
- LEQVIO (Drug) $165.37
- Korlym (Drug) $162.31
- FREESTYLE LIBRE 3 (Device) $155.34
- FARXIGA (Drug) $151.15
- XARELTO (Drug) $150.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Nashville
Susan Utley, Np, NP
Nurse Practitioner — Payments: $154,650
Brooke Faught, Np, NP
Nurse Practitioner — Payments: $75,457
Mrs. Lauren Welch, Aprn, Np-C, APRN, NP-C
Nurse Practitioner — Payments: $71,420
Patricia Morris, Np, NP
Nurse Practitioner — Payments: $28,914
Cherish Holt, Apn-Bc, APN-BC
Nurse Practitioner — Payments: $16,154
Bettina Engh, Aprn Rd, APRN RD
Nurse Practitioner — Payments: $13,695